RESUMO
Eating disorders are unique in that they inherently have much medical comorbidity both as a part of restricting-type eating disorders and those characterized by purging behaviors. Over the last three decades, remarkable progress has been made in the understanding and treatment of the medical complications of eating disorders. Yet, unfortunately, there is much research that is sorely needed to bridge the gap between current medical knowledge and more effective and evidence-based medical treatment knowledge. These gaps exist in many different clinical areas including cardiology, electrolytes, gastrointestinal and bone disease. In this paper, we discuss some of the knowledge gap areas, which if bridged would help develop more effective medical intervention for this population of patients.
Assuntos
Medicina Baseada em Evidências , Transtornos da Alimentação e da Ingestão de Alimentos , Bases de Conhecimento , Humanos , PesquisaRESUMO
Anorexia nervosa (AN) has the highest mortality rate of all psychiatric illnesses due to the widespread organ dysfunction caused by the underlying severe malnutrition. Starvation causes hepatocyte injury and death leading to a rise in aminotransferases. Malnutrition-induced hepatitis is common among individuals with AN especially as body mass index decreases. Acute liver failure associated with coagulopathy and encephalopathy can rarely occur. Liver enzymes may also less commonly increase as part of the refeeding process due to hepatic steatosis and can be distinguished from starvation hepatitis by the finding of a fatty liver on ultrasonography. Individuals with AN and starvation-induced hepatitis are at increased risk of hypoglycemia due to depleted glycogen stores and impaired gluconeogenesis. Gastroenterology and hepatology consultations are often requested when patients with AN and signs of hepatitis are hospitalized. It should be noted that additional laboratory testing, imaging, or liver biopsy all have low diagnostic yield, are costly, and potentially invasive, therefore, not generally recommended for diagnostic purposes. While the hepatitis of AN can reach severe levels, a supervised increase in caloric intake and a return to a healthy body weight often quickly lead to normalization of elevated aminotransferases caused by starvation.
Assuntos
Anorexia Nervosa/epidemiologia , Hepatopatias/epidemiologia , Fígado/fisiopatologia , Estado Nutricional , Anorexia Nervosa/diagnóstico , Anorexia Nervosa/dietoterapia , Anorexia Nervosa/fisiopatologia , Ingestão de Energia , Humanos , Fígado/metabolismo , Fígado/patologia , Hepatopatias/diagnóstico , Hepatopatias/dietoterapia , Hepatopatias/fisiopatologia , Testes de Função Hepática , Avaliação Nutricional , Valor Preditivo dos Testes , Prevalência , Recuperação de Função Fisiológica , Fatores de Risco , Resultado do TratamentoRESUMO
OBJECTIVE: Evaluation of liver dysfunction in patients with severe anorexia nervosa (AN) has typically been limited to small case series. We report an investigation into the admission characteristics and clinical outcomes associated with liver dysfunction in a large cohort of adults hospitalized for medical stabilization of severe AN. METHODS: We retrospectively evaluated electronic medical records to quantify the cumulative incidence of elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT). We compared mean (±SD), frequencies (%), and median (IQR) values of clinical covariates of interest by incidence of liver enzyme elevation. The study included 181 adults, admitted for medical stabilization of AN, from October 1, 2008 to December 31, 2013. RESULTS: AST and ALT were mildly elevated in 27.6% of patients and severely elevated (more than three times the upper limit of normal) in 35.4% of patients. On admission, patients with severely elevated liver enzymes had a lower body mass index (BMI) (11.9 ± 1.8 kg/m(2) vs.13.3 ± 1.7 kg/m(2)), lower percentage ideal body weight (56.5% ± 7.7% vs. 63.5% ± 8.3%), and lower prealbumin (64% vs. 37%) compared with the rest of the cohort (p < 0.001). While hospitalized, patients with severely elevated liver enzymes more often developed hypoglycemia, hypophosphatemia, and experienced longer lengths of stay (p < 0.001). DISCUSSION: Elevated liver enzymes are common in our patient population with severe AN. Liver enzymes reached near normal values by the time of discharge. Severely elevated liver enzymes were associated with a lower BMI and the development of hypoglycemia.
Assuntos
Alanina Transaminase/sangue , Anorexia Nervosa/enzimologia , Aspartato Aminotransferases/sangue , Hepatopatias/enzimologia , Adulto , Anorexia Nervosa/complicações , Anorexia Nervosa/fisiopatologia , Índice de Massa Corporal , Peso Corporal , Feminino , Hospitalização , Humanos , Hipoglicemia/etiologia , Hipofosfatemia/etiologia , Incidência , Hepatopatias/epidemiologia , Hepatopatias/etiologia , Masculino , Pré-Albumina/análise , Valores de Referência , Estudos Retrospectivos , Adulto JovemRESUMO
The clinical presentation and medical complications of severe anorexia nervosa among males were examined to further the understanding of this increasingly prevalent condition. Fourteen males were admitted to a medical stabilization unit over the study period. Males with severe anorexia nervosa were found to have a multitude of significant medical and laboratory abnormalities, which are in need of treatment via judicious, nutritional rehabilitation and weight restoration to prevent additional morbidity and to facilitate transfer and admission to traditional eating disorder programs.